Evidence map›Paper›PMID 39360131›Full record

Article3D printing and additive manufacturing2024

The Exploration of Ink Formulations in Binder Jet 3D Printing Drugs.

Shanshan Wang, En Liang, Xiaolu Han, Hui Zhang, Conghui Li, Mingyuan Li, Peng Yu, Zengming Wang, Xiang Gao, Aiping Zheng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in 3D printing and additive manufacturing, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shanshan WangCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, China.ORCID https://orcid.org/0000-0001-6979-5647
En LiangInstitute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Academy of Military Sciences, Beijing, China.
Xiaolu HanInstitute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Academy of Military Sciences, Beijing, China.
Hui ZhangInstitute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Academy of Military Sciences, Beijing, China.
Conghui LiInstitute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Academy of Military Sciences, Beijing, China.
Mingyuan LiCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, China.
Peng YuCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, China.
Zengming WangInstitute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Academy of Military Sciences, Beijing, China.
Xiang GaoInstitute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Academy of Military Sciences, Beijing, China.
Aiping ZhengInstitute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Academy of Military Sciences, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The application of binder jet 3D printing technology in the pharmaceutical field is developing rapidly. The properties of the ink are very important, affecting the stability of the ejection and the precision of the finished product, but there is a great lack of research on pharmaceutical inks. This study used solvents and excipients commonly used in pharmaceuticals to quantify the printability of inks using printability

Indexed as

3D printed drugsbinder jet 3D printingdroplet ejectionfluid mechanicsprinting inks

Identifiers

PMID39360131
PMCPMC11443109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.